FAQs | Site Map | Links | Home
January 13, 2009
skip navigation

  arrow Bill Tracking

  (spacer) Legislative Updates

  (spacer) Public Laws

  (spacer) Hearings

  (spacer) Committees of
   (spacer) Interest to NIH


  (spacer) OLPA


margin frame

Bill TrackingBill Tracking
(spacer)

Senate Bills - 108th Congress

arrow indicating current page Session I | Session II

S. 666—Biological, Chemical, and Radiological Weapons Countermeasures Research Act

On March 19, 2003, Senator Joseph Lieberman (D-CT) introduced S. 666, the Biological, Chemical, and Radiological Weapons Countermeasures Research Act. Provisions would authorize the Director of NIH to award partnership challenge grants to promote joint ventures between the Agency, its grantees, and for-profit biotechnology, pharmaceutical, and medical device industries for the development of countermeasures and research tools. The Director would be required to issue regulations within 90 days of enactment of the bill to implement the awarding of these grants. Authorized would be $200 million for each of the FYs 2004 through 2008. S. 666 was referred to the Senate Committee on Finance.

Legislative Update (August 2003): Biological, Chemical, Radiological, and Nuclear Defense

(spacer)

 

Privacy | Accessibility | Disclaimer    

National Institutes of Health Department of Health and Human Services USA.gov - Government Made Easy